Rocket Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RCKT and other ETFs, options, and stocks.About RCKT
Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of gene therapy treatment options for rare and devastating pediatric diseases. The firm's multi-platform development approach applies the lentiviral vector and adeno-associated viral vector gene therapy platforms.
RCKT Key Statistics
Stock Snapshot
The current Rocket Pharmaceuticals(RCKT) stock price is $3.49, with a market capitalization of 395.05M. The stock trades at a price-to-earnings (P/E) ratio of -1.89.
On 2026-08-07, Rocket Pharmaceuticals(RCKT) stock moved within a range of $3.47 to $3.71. With shares now at $3.49, the stock is trading +0.6% above its intraday low and -6.0% below the session's peak.
Trading volume for Rocket Pharmaceuticals(RCKT) stock has reached 595.7K, versus its average volume of 1.68M.
Over the past 52 weeks, Rocket Pharmaceuticals(RCKT) stock has traded between a high of $5.45 and a low of $2.53.
Over the past 52 weeks, Rocket Pharmaceuticals(RCKT) stock has traded between a high of $5.45 and a low of $2.53.
RCKT News
Danon disease is a rare, inherited genetic condition characterized by cardiomyopathy (weakening of the heart muscle), skeletal myopathy (muscle weakness) and in...
Analyst ratings
47%
of 15 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.